ShareBaz

08/07/2024

“The smart way to keep people passive and obedient is to strictly limit the spectrum of acceptable opinion, but allow very lively debate within that spectrum....”
― Noam Chomsky,

17/09/2023

Share Market Motivation Story

03/09/2023

Alert: Loan App Scam

#लोनस्कैम

18/08/2023

For Hindi Readers... join this group

WhatsApp Group Invite

24/06/2023

📢 News: Aurobindo Pharma Makes Exciting Strides in the Pharma Industry! 🌟💊

We're thrilled to share that Aurobindo Pharma has witnessed a remarkable 2.5% rise in share price on June 23, thanks to a significant licensing agreement made by one of its subsidiaries. 📈💼

Aurobindo Pharma's wholly owned subsidiary, Eugia Pharma Specialities Limited (Eugia), has entered into a voluntary sub-licensing pact with Medicines Patent Pool (MPP) for Nilotinib Capsules. This strategic collaboration allows Eugia to develop and market these capsules, originally developed by Novartis, for the treatment of chronic myeloid leukemia in 44 low and middle-income countries. 🌍💪

This momentous achievement signifies Aurobindo Pharma's commitment to making healthcare more accessible and affordable in these countries. The production of Nilotinib capsules will take place at Eugia Pharma's state-of-the-art facility in Medchal, Telangana's Malkajgiri district. 🏭💊

Vice Chairman & Managing Director, K Nithyananda Reddy, expressed his excitement about this milestone and its impact on cancer treatment. He stated, "We are excited that Eugia has been granted the voluntary license from MPP to develop, manufacture & distribute generic Nilotinib Capsules in select markets. These are the first sublicence agreements that MPP has signed for a cancer treatment that will be made available in the LMIC, through this license." 🎉💪

With this breakthrough, Aurobindo Pharma strengthens its position in the generic oncology space and adds another valuable asset to its oncology portfolio. The company is eager to commence the supply of this crucial product to help reduce the risk of chronic myeloid leukemia (CML) in certain patients. 💊🌟

At 12.06 pm, Aurobindo Pharma's share price stood at Rs 687, marking an impressive increase of Rs 15.80 or 2.35% on the BSE. It's worth noting that the share touched a 52-week high of Rs 692 on June 19, 2023, demonstrating the company's continuous growth and potential. 📈✨

We applaud Aurobindo Pharma for this remarkable achievement and their unwavering dedication to transforming healthcare. Stay tuned for more updates on our journey towards a healthier world! 💪💊

24/06/2023

🚀 News Alert! 🎉 LIC Mutual Fund is set to acquire the schemes of IDBI Mutual Fund, bringing you a whole new level of investment opportunities! 💼💰

In a significant move, LIC Mutual Fund (LICMF) is all set to take over the schemes of IDBI Mutual Fund (IDBIMF). This means a seamless transition for you, our valued investors, into a world of enhanced benefits and expert management. 📈💼

With this acquisition, LICMF will manage, operate, and administer all of IDBIMF's schemes, ensuring top-notch performance and exceptional service. The merger will result in a stronger and more diversified portfolio, offering you greater potential for growth and stability. 💪📊

What's more, IDBI MF schemes that are getting transferred to LIC MF include a wide range of options suited to your investment preferences. From equity funds and hybrid funds to debt products, we've got you covered across multiple asset classes. 📈🌍💰

We believe in providing you with utmost transparency and flexibility. As per the norms, unitholders of IDBIMF schemes are also offered an exit option without any exit load, should they choose to exercise it. However, if you're content with the changes, you can continue to stay invested and reap the benefits of this strategic collaboration. 💼✨

Your opinion matters! The voting window is now open from June 20, 2023, until July 19, 2023. We encourage you to have your say and make your voice count by filling out the ballot form sent to you. Remember, each unitholder is entitled to one vote for every unit held. 🗳️📩

Get ready for a new chapter in your investment journey with LIC Mutual Fund! 🚀💼 Our experienced team is committed to delivering exceptional results and empowering you to achieve your financial goals. Stay tuned for more updates and exciting opportunities that lie ahead! 🌟💰

22/06/2023

🌟 HMA Agro Industries Ltd IPO! 🌟

🚀 India's Largest Frozen Buffalo Meat Products Exporter 🚀

📅 Hurry! Limited Time Offer: Open for Subscription till June 23rd, 2023 📅

Attention, investors and meat enthusiasts alike! The moment you've been waiting for is here. The highly anticipated initial public offer (IPO) of HMA Agro Industries Ltd is now open for subscription! But you only have two days left to secure your stake in this groundbreaking opportunity. Don't let it slip away!

🐃 HMA Agro Industries Ltd: The Pride of India's Meat Export Industry 🌍

Did you know that HMA Agro Industries Ltd is the largest exporter of frozen buffalo meat products in India? With a stellar reputation for quality and reliability, they have captured the hearts and taste buds of customers worldwide. Now, you have a chance to be a part of their extraordinary success story!

💼 IPO Subscription Status: Act Fast! 💼

The public issue has already garnered significant interest, with a subscription rate of 0.56 times within the first two days of bidding. The retail portion, specifically, has reached 0.39 times. This signals the immense potential this IPO holds. Market observers are closely monitoring the developments and are thrilled to witness the positive response.

📈 HMA Agro IPO GMP Today: A Steady Outlook 📉

While the grey market sentiment for HMA Agro Industries Ltd IPO has been steady with a premium of ₹25 per share, there is room for growth. Market observers note that despite the overall bullish stock market environment, the response from investors has been lukewarm. This presents an opportunity for shrewd investors like you to seize the moment and make a wise investment decision.

⏳ Time is Ticking: Make Your Move! ⏳

The clock is ticking, and the window of opportunity will soon close. Act swiftly and join the ranks of visionary investors who recognize the potential of HMA Agro Industries Ltd. This IPO has the power to transform your investment portfolio and pave the way for exciting returns. The future is now, and it's in your hands!

💰 Don't Delay, Apply Today! 💰

Don't let this chance pass you by. Apply for the HMA Agro Industries Ltd IPO today and secure your spot in India's leading frozen buffalo meat products exporter. The world is hungry for their exceptional offerings, and you can be part of their continued success. Act now and reap the rewards of your astute investment!

20/06/2023

"🔥 URGENT: Desperate for Cash? Instant Money with No Credit Check! Unveiling the Hottest 10 Loan Apps in the United States! 💰💸"

Instant Cash with No Credit Check. Discover the Best Loan Apps for Quick Money without Credit Checks. Find the best apps to get quick money when you need it the most.

20/06/2023

📢 Exciting news! Piramal Enterprises has announced its plan to sell its entire stake of 8.34% in Shriram Finance via a block deal. According to sources privy to the development, this move is expected to take place soon.

To accomplish this, Piramal Enterprises will be selling approximately 3.1 crore shares it currently holds in the non-banking financial company. The floor price for the block deal is anticipated to be Rs 1,483 per share, indicating a discount of approximately 5% from the current market price of Shriram Finance's stock, which stands at Rs 1,559.45 on the BSE.

We're pleased to share that investment banking firm Morgan Stanley will be the sole broker for this block deal, further ensuring a smooth transaction process.

Stay tuned for more updates on this exciting development! 🎉

19/06/2023

🔮 Outlook for June 20 🔍✨

The local market witnessed a risk-off sentiment, influenced by global equity market sell-offs, leading to profit-taking in banking, auto, telecom, and FMCG stocks. While India's macroeconomic indicators show promise, global headwinds may contribute to periodic bouts of selling.

On intraday charts, the Nifty is displaying a higher high and higher low series formation, indicating potential for further upward momentum from current levels.

For traders, 18,680 is a crucial support level to watch. Above this level, the index may retest the range of 18,850-18,900. Conversely, if the index falls below 18,680, traders might consider exiting their long positions, as the index could slide towards 18,650-18,610.

According to Jatin Gedia, Technical Research Analyst at Sharekhan by BNP Paribas, the Nifty opened positively but encountered selling pressure throughout the day, ultimately closing on a negative note. Recent sessions have shown increased volatility, which can be a sign of a potential top. Confirmation of this would require breaching the crucial support zone currently at 18,650-18,600.

Conflicting signals from daily and hourly momentum indicators further contribute to the uncertainty and volatility. Be prepared for continued volatility in upcoming trading sessions. Key support levels to keep in mind are 18,650-18,600, while 18,880-18,900 serves as crucial resistance.

Regarding the Bank Nifty, the index is expected to consolidate within the range of 43,400-44,500 in the short term. The recent swing high of 44,500 acts as a strong resistance, while the 40-day exponential moving average at 43,400 provides crucial support. A decisive breakthrough beyond these levels could indicate a trending move in that direction.

Stay informed and adapt your strategies accordingly.

19/06/2023

📢 Market Update 📈📉

Today's trading session was marked by high volatility and a negative trend as global markets weakened and most sectors experienced selling pressure.

The Sensex closed 216.28 points lower at 63,168.30, while the Nifty ended down 70.50 points at 18,755.50.

Although the market initially showed promise, reaching close to record highs, profit booking erased the early gains, resulting in a session that concluded near the day's lows.

Notable losers on the Nifty included Adani Enterprises, Kotak Mahindra Bank, Hero MotoCorp, Axis Bank, and Adani Ports. On the other hand, HDFC Life, Bajaj Finance, Bajaj Finserv, Tech Mahindra, and TCS emerged as gainers.

The auto, bank, realty, power, and FMCG sectors experienced a decline of 0.5% each, while the PSU bank index rose by 1%, and the Information Technology index witnessed a 0.4% increase.

The BSE midcap and smallcap indices remained relatively unchanged.

Jindal Steel, Shriram Finance, and Dr Lal PathLabs observed long build-up, whereas Adani Enterprises, Vodafone Idea, and Marico showed short build-up.

In terms of individual stocks, BHEL, Shriram Finance, and India Cements experienced a significant increase in trading volume, exceeding 500%.

More than 200 stocks on the BSE reached their 52-week high, including Zydus Lifesciences, ABB India, ITC, L&T, One 97 Communications, Texmaco Rail & Engineering, PNB Housing Finance, Cholamandalam Investment and Finance Company, Mazagon Dock Shipbuilders, and Exide Industries.

Stay updated with the latest market news and trends.